Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Hu B, Huang S, Yin L. The Cytokine Storm and COVID-19. J Med Virol. 2020 Jun 27;https://doi.org/10.1002/jmv.26232. Online ahead of print.
2. World Health Organization. WHO R&D Blueprint Novel Coronavirus COVID-19 Therapeutic Trial Synopsis 2020a, available at https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.
3. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19 - final report. N Engl J Med. 2020; 383: 1813-26.
4. Rubio-Rivas M, Corbella X, Formiga F, et al. Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 Registry. J Clin Med. 2021; 10: 2214.
5. Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clin Esp. 2020; 220: 480-94.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献